More on ANTX
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $5.48 |
|
|||
| Open | $5.48 | ||||
| 52 Wk High | $48.59 | ||||
| 52 Wk Low | $40.72 | ||||
| Day High | $5.48 | ||||
| Day Low | $5.48 | ||||
| P/E | N/A | ||||
| EPS | $-0.01 | ||||
| Volume | 25,714 | ||||
- Form 3 AN2 Therapeutics, Inc. For: Aug 24 Filed by: Trenor Cameron C. III
- AN2 Therapeutics names Cameron Trenor as chief medical officer
- AN2 Therapeutics Appoints Cameron Trenor, M.D., as Chief Medical Officer
- Form 4 AN2 Therapeutics, Inc. For: Aug 17 Filed by: Readnour Robin Shane
- Form 144 AN2 Therapeutics, Inc. Filed by: Readnour Robin Shane
- Form 4 AN2 Therapeutics, Inc. For: Aug 14 Filed by: Zakrzewski Joseph S
- AN2 Therapeutics, Inc. (ANTX) Tops Q2 EPS by 5c
- Form 10-Q AN2 Therapeutics, Inc. For: Jun 30
- Form 8-K AN2 Therapeutics, Inc. For: Aug 11
- AN2 Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business and Scientific Highlights
Entities mentioned with ANTX
- FDA | View Related Stories »
- 13G | View Related Stories »
- Earnings | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- IPO | View Related Stories »
- Cowen & Co | View Related Stories »
- Show More...
